Page 19 - Pharma

PPP model can make India one of top 5 global pharma innovation hubs: Study

Government's decision to allow 100% FDI under automatic route in the pharma sector will further enhance R&D activity in India, says a joint study of Assocham and TechSci Research

Department of Pharma consults stakeholders on pricing mechanism for stents

The move aims to develop a science, safety and efficacy based price determination process for drug eluting stents, which have been recently included in NLEM (National List of Essential Medicine)

US FDA grants approval to Jubilant's hypertension drug felodipine

The approved product, felodipine extended-release tablet (2.5 mg, 5 mg, and 10 mg), is the generic version of Plendil tablets of AstraZeneca

US patent office invalidates 2 patents of Teva's blockbuster drug Copaxone

The rule is in favour of Mylan, who has partnered with Natco Pharma in challenging the patent of the multiple sclerosis drug, Copaxone 40 mg injection, which has annual US sales of $3.3 bn

European drug regulator accepts Mylan & Biocon application for biosimilar trastuzumab

This is the second biosimilar developed by the two companies - who are collaborating for a broad portfolio of biosimilars and insulin analogs - that has been accepted for review in Europe

Molex acquires pharma packaging firm Phillips-Medisize

The Wisconsin-based global design and manufacturing company specialises in custom solutions that require advanced moulding and assembly for medical device OEMs

Jubilant Life receives US FDA approval for hypertension drug telmisartan

The approved product - telmisartan tablet - is a generic version of Boehringer Ingelheim Pharmaceuticals' Micardis tablet

Germany's Fresenius Kabi to invest $ 250 mn to expand US manufacturing plant

The expansion, which will take place over the next 10 years, will significantly increase Fresenius Kabi's capacity to produce injectable generic pharmaceuticals

Perrigo acquire US distributor of healthcare products Geiss, Destin & Dunn

Acquisition will further strengthen Perrigo's US distribution and retail network, providing it direct access to the non-mass retail market

Pfizer to acquire oncology specialist Medivation for $ 14 bn

The addition of Medivation will strengthen Pfizer's position in oncology, one of its key focus areas to drive growth in the long-term

Commerce Ministry wants an external office of WIPO in India

If established, the Indian office will be the sixth external office of WIPO globally. The other five offices are located in Brazil, China, Japan, Russia and Singapore

Omkar Specialty commissions expanded capacity in Badlapur

With the capacity of the unit 1, which will manufacture advanced intermediates for pharmaceuticals, has been increased by 50 percent from 600 MTPA to 900 MTPA

Lupin receives CDSCO approval for indigestion drug acotiamide

The current market for plain gastrointestinal (GI) prokinetics and combinations is estimated to be around Rs 2,640 crores growing at 14 percent, according to IMS Health

Fortis Healthcare board approves scheme for diagnostics business demerger

As per the scheme, SRL (Fortis Healthcare's business engaged in diagnostics) will be merged with Fortis Malar in the first step. Subsequently, the name of Fortis Malar will be changed to SRL

Narayana Health opens robotic surgery training institute

Institute of Robotic Surgery, based in Bangalore and supported by Infosys Foundation, will train doctors in robotic surgery for various cancers

Piramal Enterprises buys US-based Ash Stevens to tap high potency APIs market

The company will buy the US-based contract development and manufacturing organisation (CDMO) for a total consideration of $ 42.95 million (about Rs 286 crores)

BARC and Sree Chitra Tirunal Institute to jointly develop deep brain stimulator

DBS device, which is used in typical neurological conditions such as Parkinson's disease, dystonia, etc, is currently being imported, limiting its wider usage due to the high cost

Govt plans to open 300 Amrit pharmacies to dispense low-cost drugs

The Amrit retail outlets, which sell drugs at highly discounted rates, are aimed at reducing the burden of out-of-pocket expenses on patients

Lonza buys InterHealth Nutraceuticals for $ 300 million

Acquisition will strengthen Lonza's specialty nutritional ingredients portfolio

US FDA issues establishment inspection report for Natco's Kothur facility

The Kothur facility predominantly caters to regulated international markets, including USA